The Drugs Technical Advisory Board (DTAB) has opined that manufacturers of ranitidine - a drug used to treat indigestion, heartburn and acid reflux - should monitor the N-nitrosodimethylamine (NDMA) ...

The Indian Council of Medical Research (ICMR) may now conduct a study to assess the safety of the popular antacid, Ranitidine, News18 has learnt. Facing controversy due to cancer-causing concerns, the ...

Zantac owners Zantac hit the US market as a prescription drug in 1983 before transforming into an over-the-counter heartburn treatment in 1995. GSK and Warner Lambert developed it as part of a ...

Ranitidine was first developed in 1981 in Europe by Glaxo Holdings Ltd, now part of GlaxoSmithKline (GSK) PLC. It got its first American approval in 1983, along with 31 other countries. It was ...

Get up-to-date information on side effects, precautions, warnings, and proper storage to ensure safe usage. Explore Ranitidine brand names commonly used in India and internationally, along with ...

Zantac’s Developer Settles Lawsuits Claiming Cancer Link GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

Morgan Stanley previously suggested the Zantac cases could cost GSK as much as $30bn to settle, although other analysts have since put the figure at somewhere between $2bn and $8bn.

Sources " Zantac's Maker Kept Quiet About Cancer Risks for 40 Years." Bloomberg. Anna Edney, Susan Berfield, and Jef Feeley. February 15, 2023.

Concerns have been raised that ranitidine can degrade into a cancer-causing agent, particularly under certain storage conditions. Additionally, consuming certain foods while taking ranitidine may ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...